Aprepitant affects pharmacokinetics of corticosteroids

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1401, 2003-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant

By Bergman Arthur J.

Clinical Pharmacokinetics, Vol. 44, Iss. 6, 2005-01 ,pp. : 637-647

Adis International

Access to resources Recommend Favorite

Fluoxetine affects the pharmacokinetics of metoclopramide

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The pharmacokinetics (PK) of aprepitant are not affected in patients with end-stage renal disease (ESRD) or severe renal impairment

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Oral Ciprofloxacin Affects the Pharmacokinetics of Paracetamol in Saliva

By Mahmoud Mohamed Issa

Clinical Drug Investigation, Vol. 26, Iss. 4, 2006-01 ,pp. : 223-226

Adis International

Access to resources Recommend Favorite

Probenecid Affects the Pharmacokinetics of Ofloxacin in Healthy Volunteers

By Nataraj B.

Clinical Drug Investigation, Vol. 16, Iss. 3, 1998-09 ,pp. : 259-262

Adis International

Access to resources Recommend Favorite